Th1-polarized T cell response (Th1 response) (Th1 response)

The Th1-polarized T cell response is a specialized arm of the adaptive immune system defined by the differentiation of naive CD4+ T cells into Th1 effector cells (StatPearls, NBK541037). This polarization is driven by the cytokines interleukin-12 (IL-12) and interferon-gamma (IFN-γ), which signal through the STAT1 and STAT4 pathways to induce the master transcription factor T-bet (TBX21) (PubMed, 19144319). The primary function of Th1 cells is to coordinate cell-mediated immunity against intracellular pathogens, such as viruses and mycobacteria, by activating macrophages and promoting the activity of CD8+ cytotoxic T cells (Janeway's Immunobiology). In the context of disease, an exaggerated Th1 response is frequently associated with the pathogenesis of autoimmune disorders like Crohn's disease, rheumatoid arthritis, and multiple sclerosis (Nature Reviews Immunology, 2003). Conversely, a robust Th1 response is critical for effective anti-tumor immunity, making it a focal point for cancer immunotherapy (PubMed, 24751537). Pharmacological modulation of this response includes the use of monoclonal antibodies like Ustekinumab to block Th1-inducing cytokines or the administration of recombinant cytokines like Interferon gamma-1b to enhance immune activity (PubChem, CID 135315435).

Other names

Type 1 helper T cell responseTh1 immunityCell-mediated immune responseTh1-type cytokine profile

Modulation of the Th1 cytokine axis, primarily through the inhibition or supplementation of cytokines like IL-12 and IFN-gamma to alter T cell differentiation and effector function.